It has been noticed frequently that CRP plasma levels rise in AMD patients versus controls [60]: CRP possesses a CFH-binding site which enables it with a regulatory role, and, therefore, it can indirectly trigger the inflammatory response. The gene discussed is CRP; the disease is age-related macular degeneration.